logo
  Join        Login             Stock Quote

Covidien (COV) Receives FDA 510(K) For Idrive Ultra Powered Stapling System

 August 28, 2012 07:46 AM
 


(By Balaseshan) Surgical device maker Covidien plc (NYSE:COV) said it has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iDrive Ultra powered stapling system.

The new stapling system has fully powered, reusable, battery-operated endoscopic surgical stapler. The system will be available in the U.S. beginning in the fourth quarter of 2012.

Powered stapling technology took a big step forward in 2009, as Covidien acquired Power Medical Interventions (PMI) and its iDrive powered stapling technology. Covidien enhanced the iDrive powered stapling system to improve performance in the surgical setting, building on the technology pioneered with older models.

[Related -S&P Buys That Pass The Buffett Test]

The new iDrive Ultra system, which features one-handed push-button operation and unlimited articulation, eliminates the need for manual firing force and improves maneuverability, compared with traditional endomechanical staplers.

The iDrive Ultra system is the second offering in Covidien's line of powered stapling devices and the first that is compatible with the company's entire portfolio of Endo GIA reloads with Tri-Staple technology for use in laparoscopic and open surgical procedures.

The iDrive Ultra system combines the precision and control of a powered device with proprietary Tri-Staple technology that provides less stress on tissue during compression and clamping, potentially greater perfusion into the staple line and the ability to manage tissue variability.

[Related -Dividend Roundup: INTC, HPQ, COV, MOV, WASH]

The iDrive Ultra powered stapling system is designed for multi-patient use, thus streamlining operating room inventory management, and offers an environmentally friendly benefit by reducing medical waste.

"Laparoscopic surgery can be an exceptionally labor-intensive endeavor that requires a high level of accuracy within a very restricted anatomical space. The iDrive Ultra powered stapling system will enable surgeons to operate through restricted anatomical space with greater precision, compared with traditional endomechanical staplers," said Paul Hermes, Vice President, Chief Technology Officer, Covidien Surgical Solutions.

COV closed Monday's regular session down 0.13% at $55.55. The stock has been trading between $41.35 and $57.86 for the past 52 weeks.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageDeath Cross More Of A Buy Signal?

With the recent weakness in the equity markets, many stocks' and stock indices' chart patterns have traced read on...

article imageKey Price Planning Levels Updated for Chipotle

After a huge price surge from $600 to $760, Chipotle (CMG) shares retraced to a critical “Make or Break” read on...

article imageChina Growth and Market Structural Integrity Top List of Fear Poll Concerns

After a hiatus of almost a year (the October 2014 pullback, to be exact), I have reprised the VIX and More read on...

article imageIs The Treasury Market Still Expecting Moderate US Growth?

The roller-coaster ride in global markets in recent weeks has raised new doubts about economic growth in read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.